Business Context and Reporting Period
The Gorman-Rupp Company filed its Form 10-Q for the six-month period ended June 30, 1995. The company, incorporated in Ohio, manufactures pumps and related equipment. The report covers the second quarter and the first half of 1995, comparing results to the same periods in 1994.
Key Financial Metrics
| Metric (in thousands) | Six Months Ended June 30, 1995 | Six Months Ended June 30, 1994 |
|---|---|---|
| Net Sales | $74,069 | $72,121 |
| Net Income | $4,662 | $5,583 |
| Net Income Per Share | $0.54 | $0.65 |
| Operating Cash Flow | $5,259 | $5,575 |
| Cash and Cash Equivalents (Ending) | $3,031 | $2,145 |
| Total Debt (Current + Long Term) | $9,131 | $8,215 |
| Current Ratio | 3.2:1 | 3.7:1 (Dec 31, 1994) |
Profit Margins (Six Months): Net income margin decreased to 6.3% in 1995 from 7.7% in 1994. Cost of products sold as a percentage of net sales increased to 74.9% from 73.5%.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased by 2.7% ($1.9 million) for the six-month period, driven primarily by increased sales at the Mansfield Division.
- Profit Decline: Despite higher sales, net income decreased by 16.5% ($921,000). This was caused by a disproportionate rise in costs.
- Cost Pressures: Cost of products sold rose due to materials required for increased sales and higher medical insurance costs. Product mix changes also contributed to a higher cost percentage.
- Expense Increases: Selling, general, and administrative expenses rose by approximately 8.6%, attributed to higher consulting fees and interest expenses.
- Liquidity: The current ratio declined from 3.7 to 1 at year-end 1994 to 3.2 to 1 at June 30, 1995, though management maintains the position is healthy.
Outlook, Risks, and Management Commentary
Management stated that the company continues to finance capital expenditures and working capital through internally generated funds and bank financing. They reported adequate working capital, borrowing capacity, and a healthy liquidity position.
Risks and Contingencies:
- Cost Volatility: Rising medical insurance costs and material costs are impacting margins.
- Product Mix: Shifts in product mix are resulting in lower gross margins.
- Interim Results: Management noted that operating results for the interim period are not necessarily indicative of full-year results.
The filing does not provide specific forward-looking guidance or numerical forecasts for the remainder of 1995.
Investor Verification Checklist
- Verify the sustainability of the 2.7% sales growth given the 16.5% decline in net income.
- Confirm the trajectory of medical insurance costs and their impact on future margins.
- Review the specific product mix changes causing the increase in cost of goods sold percentage.
- Assess the impact of increased consulting fees and interest expenses on future operating leverage.
- Monitor the trend of the current ratio, which has declined from 3.7 to 3.2 over the last six months.